2
Book Reviews Drug Metabolism Databases and High-Through- put Testing During Drug Design and Develop- ment. Edited by Paul W. Ehrhardt. International Union of Pure and Applied Chemistry, Blackwell Sci- ence, Ltd., Malden, MA. 1999. 340 pp. 19 x 25 cm. ISBN 0-632-05342-9. $60.00. This book is the result of deliberations of a Working Party of the IUPAC, assembled to consider the topic Metabolism Databases and Their Potential Utility in the Development of New Drugs. Paul Ehrhardt, the techni- cal editor for this volume, was the chair of the Working Party. His introduction provides a historical perspective and highlights some of the biological considerations that contribute to poor predictability of drug metabolism in humans. The book is arranged in three sections. The first contains several historical case studies describing the use of metabolism expert systems or databases in the pharmaceutical industry. The middle section con- tains monographs on various techniques for high- throughput screening of drug candidates, descriptions of ex vivo models of drug metabolism, and chapters on the use of metabolism databases in drug design. The final section of the book, entitled Emerging Products, contains contributions from vendors of commercial products. Expert systems and metabolism databases are described briefly. The appendix contains tables of com- mercially available drug metabolism databases and contract research organizations that conduct high- throughput screening. A glossary is also provided. The first section of the book, Case Studies, is well- balanced and provides thought provoking and enter- taining examples of the utility of various databases available from 1985-1995. Several evaluations of the effectiveness of expert systems to predict drug metabo- lism are presented. Specific drug examples from indus- trial scientists illustrate the difficulty of prediction and indicate the difficulties in quantitative prediction with "expert" systems. Descriptions of searchable metabolism databases used at Parke-Davis, Eli Lilly, and Baeyer provide clear examples of what information should be included in these databases. However, a chapter sub- mitted from Daiichi Pharmaceutical consists almost entirely of metabolic schemes for two drugs and a discussion is missing. The section ends with a chapter on the design and development of two prodrugs, esmolol and imidazolone, but this seems out of place with the previous chapters. The organization of the middle section of the book is disjointed. The first chapter describes the determination of drug permeability of the Caco-2 colon cell line for prediction of gastrointestinal absorption and would have been more logically placed with the other chapters on high-throughput screening. Unfortunately, the use of the Caco-2 system to study the role of intestinal transporters and efflux pumps such as P-glycoprotein in drug absorption is not included in this chapter. This section includes a chapter on preclinical drug metabo- lism screening, screening for inhibition of P-450 me- tabolism, and pharmacokinetic screening by the N-in- one (cassette dosing) technique. These chapters are well- written, and they critically evaluate the techniques and problems arising from high-throughput screening. The second chapter in the section the contains a lengthy introduction on the cytochrome P450 system. This may be useful to novices in the drug metabolism field, but the rest of the book appears to be targeted to a more knowledgeable audience. The second half of the chapter describes the administration of a drug cocktail consisting of several individual P450 enzyme substrates to predict the clearance of drugs in an individual through a “handprint strategy”. This material does not relate to either high-throughput screening or ex vivo models of drug metabolism. A commentary on the importance of developing databases of drug interactions (by using antiepileptic drug examples) would have been more logically placed after the high-throughput screen- ing chapters. Three short chapters on model systems to predict P450-mediated metabolism are located be- tween chapters on high-throughput screening of drug metabolism. Chapters on the use of microorganisms as model systems of drug metabolism and synthetic met- alloporphyrins as P450-like catalysts highlight other experimental techniques for ex vivo prediction of oxida- tive metabolism. An interesting chapter describes the use of a database called the Encyclopedia of E. coli Genes and Metabolism (EcoCyc) used to identify novel targets for antimicrobial drug discovery. The section ends with more traditional discussions of the use of metabolism databases to design prodrugs and codrugs and the design of soft drugs. The final section of the book was written by several commercial vendors (not associated with the IUPAC Working Group) and describes products such as Metab- polExpert, META, and Metabolite. Descriptions of two metabolic databases from Synopsys and LHASA UK, Ltd. are included. These chapters are brief and descrip- tive in nature, but along with the appendix will be useful for those in the pharmaceutical industry who are interested in a general overview of the currently avail- able products. The potential audience for this book lies primarily in the pharmaceutical industry. This compendium would be a very useful starting point for those involved in data management of drug metabolism results, although a chapter or two from experts in bioinformatics might have been an interesting addition to the book. The individual monographs are not highly detailed and individuals involved in programming and database management will use the book primarily as a source for reference citations. Academic libraries that support groups of researchers in drug metabolism or drug discovery may wish to obtain this volume of the IUPAC series, but the book should not be considered as a Journal of Medicinal Chemistry, 2000, Vol. 43, No. 16 3197

Drug Metabolism Databases and High-Throughput Testing During Drug Design and Development Edited by Paul W. Ehrhardt. International Union of Pure and Applied Chemistry, Blackwell Science,

  • Upload
    rory-p

  • View
    212

  • Download
    0

Embed Size (px)

Citation preview

Book Reviews

Drug Metabolism Databases and High-Through-put Testing During Drug Design and Develop-ment. Edited by Paul W. Ehrhardt. InternationalUnion of Pure and Applied Chemistry, Blackwell Sci-ence, Ltd., Malden, MA. 1999. 340 pp. 19 x 25 cm. ISBN0-632-05342-9. $60.00.

This book is the result of deliberations of a WorkingParty of the IUPAC, assembled to consider the topicMetabolism Databases and Their Potential Utility in theDevelopment of New Drugs. Paul Ehrhardt, the techni-cal editor for this volume, was the chair of the WorkingParty. His introduction provides a historical perspectiveand highlights some of the biological considerations thatcontribute to poor predictability of drug metabolism inhumans. The book is arranged in three sections. Thefirst contains several historical case studies describingthe use of metabolism expert systems or databases inthe pharmaceutical industry. The middle section con-tains monographs on various techniques for high-throughput screening of drug candidates, descriptionsof ex vivo models of drug metabolism, and chapters onthe use of metabolism databases in drug design. Thefinal section of the book, entitled Emerging Products,contains contributions from vendors of commercialproducts. Expert systems and metabolism databases aredescribed briefly. The appendix contains tables of com-mercially available drug metabolism databases andcontract research organizations that conduct high-throughput screening. A glossary is also provided.

The first section of the book, Case Studies, is well-balanced and provides thought provoking and enter-taining examples of the utility of various databasesavailable from 1985-1995. Several evaluations of theeffectiveness of expert systems to predict drug metabo-lism are presented. Specific drug examples from indus-trial scientists illustrate the difficulty of prediction andindicate the difficulties in quantitative prediction with"expert" systems. Descriptions of searchable metabolismdatabases used at Parke-Davis, Eli Lilly, and Baeyerprovide clear examples of what information should beincluded in these databases. However, a chapter sub-mitted from Daiichi Pharmaceutical consists almostentirely of metabolic schemes for two drugs and adiscussion is missing. The section ends with a chapteron the design and development of two prodrugs, esmololand imidazolone, but this seems out of place with theprevious chapters.

The organization of the middle section of the book isdisjointed. The first chapter describes the determinationof drug permeability of the Caco-2 colon cell line forprediction of gastrointestinal absorption and would havebeen more logically placed with the other chapters onhigh-throughput screening. Unfortunately, the use ofthe Caco-2 system to study the role of intestinaltransporters and efflux pumps such as P-glycoprotein

in drug absorption is not included in this chapter. Thissection includes a chapter on preclinical drug metabo-lism screening, screening for inhibition of P-450 me-tabolism, and pharmacokinetic screening by the N-in-one (cassette dosing) technique. These chapters are well-written, and they critically evaluate the techniques andproblems arising from high-throughput screening.

The second chapter in the section the contains alengthy introduction on the cytochrome P450 system.This may be useful to novices in the drug metabolismfield, but the rest of the book appears to be targeted toa more knowledgeable audience. The second half of thechapter describes the administration of a drug cocktailconsisting of several individual P450 enzyme substratesto predict the clearance of drugs in an individualthrough a “handprint strategy”. This material does notrelate to either high-throughput screening or ex vivomodels of drug metabolism. A commentary on theimportance of developing databases of drug interactions(by using antiepileptic drug examples) would have beenmore logically placed after the high-throughput screen-ing chapters. Three short chapters on model systemsto predict P450-mediated metabolism are located be-tween chapters on high-throughput screening of drugmetabolism. Chapters on the use of microorganisms asmodel systems of drug metabolism and synthetic met-alloporphyrins as P450-like catalysts highlight otherexperimental techniques for ex vivo prediction of oxida-tive metabolism.

An interesting chapter describes the use of a databasecalled the Encyclopedia of E. coli Genes and Metabolism(EcoCyc) used to identify novel targets for antimicrobialdrug discovery. The section ends with more traditionaldiscussions of the use of metabolism databases to designprodrugs and codrugs and the design of soft drugs.

The final section of the book was written by severalcommercial vendors (not associated with the IUPACWorking Group) and describes products such as Metab-polExpert, META, and Metabolite. Descriptions of twometabolic databases from Synopsys and LHASA UK,Ltd. are included. These chapters are brief and descrip-tive in nature, but along with the appendix will beuseful for those in the pharmaceutical industry who areinterested in a general overview of the currently avail-able products.

The potential audience for this book lies primarily inthe pharmaceutical industry. This compendium wouldbe a very useful starting point for those involved in datamanagement of drug metabolism results, although achapter or two from experts in bioinformatics mighthave been an interesting addition to the book. Theindividual monographs are not highly detailed andindividuals involved in programming and databasemanagement will use the book primarily as a source forreference citations. Academic libraries that supportgroups of researchers in drug metabolism or drugdiscovery may wish to obtain this volume of the IUPACseries, but the book should not be considered as a

Journal of Medicinal Chemistry, 2000, Vol. 43, No. 16 3197

reference text in drug metabolism, nor can this reviewerforesee its use as a textbook. The volume is well-editedand contains very few typographical errors. This volumeachieves its goal as a broadly based introduction to theapplication of drug metabolism databases to drugdiscovery.

Rory P. Remmel

Department of Medicinal ChemistryUniversity of Minnesota

Minneapolis, Minnesota 55455

JM000236D

10.1021/jm000236d

3198 Journal of Medicinal Chemistry, 2000, Vol. 43, No. 16 Book Reviews